Galecto Inc expected to post a loss of 31 cents a share - Earnings Preview

Damora Therapeutics

26/07/2024 13:15

* Galecto Inc  GLTO.OQ   GLTO.O  is expected to show no
change in
quarterly revenue when it reports  results on July 29
(estimated) for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Galecto Inc is for a
loss
of 31 cents per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Galecto Inc
is
$5.50​, above​ its last closing price of $0.56. ​​​

This summary was machine generated July 26 at 12:15 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)